Strong first-day trading for iX Biopharma
Shares close trading up 21.7 per cent at S$0.56 after intra-day high of S$0.64
Singapore
SPECIALTY pharmaceutical company iX Biopharma made a strong trading debut on the Singapore Exchange Catalist board on Wednesday.
Shares of iX Biopharma, the second healthcare company in less than two months to breathe life into an otherwise moribund initial public offering (IPO) market, kicked off trading at S$0.495, 3.5 Singapore cents or 7.6 per cent above its IPO price of S$0.46.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
DBS customers unable to log into Digibank, PayLah! on Thursday
Japan’s Sumitomo Corp net profit down 32% on Madagascar one-off loss
Moody's tops quarterly profit estimates on strong product demand
Hong Kong regulator brings insider trading charges against Segantii and its founder
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Moderna beats quarterly estimates as cost-cutting pares losses